Cancer Therapy News and Research

RSS

Nano-sized copper compounds together with immunotherapy can kill cancer cells

An interdisciplinary team of scientists from KU Leuven, the University of Bremen, the Leibniz Institute of Materials Engineering, and the University of Ioannina has succeeded in killing tumour cells in mice using nano-sized copper compounds together with immunotherapy. After the therapy, the cancer did not return.

9 Jan 2020

New method uses MRI, machine learning to forecast genetic mutations in glioma tumors

Researchers at Osaka University have developed a computer method that uses magnetic resonance imaging (MRI) and machine learning to rapidly forecast genetic mutations in glioma tumors, which occur in the brain or spine. The work may help glioma patients to receive more suitable treatment faster, giving better outcomes.

9 Jan 2020

Administering enzalutamide results in significant increase in PSMA density on tumor surface

When a non-scientist tries to imagine a scientist, the image that often arises is one of a somewhat remote, rather idealistic genius sitting alone in their room or laboratory and somehow discovering the most amazing things without every having contact with the 'normal' world.

9 Jan 2020

United States sees unprecedented fall in deaths from cancer

The death rate from cancer in the US has seen the greatest fall from 2016-2017 since rates started to fall in 1992 says the ACS.

9 Jan 2020

Study demonstrates feasibility of giving entire course of radiation in less than a second

Cancer patients may one day be able to get their entire course of radiation therapy in less than a second rather than coming in for treatment over the course of several weeks, and researchers in the Abramson Cancer Center of the University of Pennsylvania have taken the first steps toward making it a reality.

9 Jan 2020

PCORI announces new research funding opportunities to improve patient-centered outcomes

Following congressional reauthorization of its funding in December 2019, the Patient-Centered Outcomes Research Institute (PCORI) began accepting new proposals for research designed to help patients and those who care for them to weigh their options and make better-informed healthcare decisions.

9 Jan 2020

Researchers identify new mechanism associated with p53 mutation

More than half of cancer cases worldwide are associated with genetic mutations in p53, the protein responsible for protecting DNA from changes that can lead to cancer.

9 Jan 2020

Step counters could play role in predicting lung cancer treatment outcomes

Numerous studies have shown that monitoring physical activity promotes better health – from reducing body mass index to watching for signs of hypertension, for example. A new study suggests step counters could play yet another role: predicting outcomes for people undergoing chemoradiation therapy for lung cancer.

8 Jan 2020

Report highlights steady 26-year decline in overall cancer mortality

The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

8 Jan 2020

Researchers capture light emission from the eye of a patient undergoing radiotherapy

For decades, theories have existed to explain patient reports of seeing light flashes during radiation therapy, even with their eyes closed.

7 Jan 2020

Low intensity pulsed ultrasound selectively targets cancer cells while sparing healthy cells

Doctors have used focused ultrasound to destroy tumors in the body without invasive surgery for some time. However, the therapeutic ultrasound used in clinics today indiscriminately damages cancer and healthy cells alike.

7 Jan 2020

New drug compounds thwart master regulator of tumor growth, metastasis

Scientists have developed new drug compounds that thwart the pro-cancer activity of FOXM1, a transcription factor that regulates the activity of dozens of genes.

7 Jan 2020

Novel artificial intelligence algorithm helps detect brain tumor

Researchers have developed a new imaging technique and artificial intelligence algorithm that can help identify brain tumors.

7 Jan 2020

Aspirin’s benefits may extend beyond heart health to colorectal cancer treatment

The benefits of a daily aspirin may extend beyond heart health to colorectal cancer treatment, say City of Hope researchers who have found aspirin appears to reduce tumor growth and inhibit recurrence of the disease.

6 Jan 2020

Researchers study new immunogenic properties of already existing anti-cancer drugs

The world scientific community is waging a difficult and prolonged war on cancer. New research in the field of immunogenic cell death can extend the area of drugs application and ensure patients' protection from relapse after therapy.

3 Jan 2020

New radiotracer can provide insights into how the heart recovers after myocardial infarction

Insights into how the heart recovers after myocardial infarction (heart attack) can be obtained with a new radiotracer that targets fibroblast activity prior to it causing permanent damage.

2 Jan 2020

New combination of antibodies leads to more effective tumor destruction

The simultaneous use of antibodies based on two differing mechanisms of action leads to a more effective destruction of tumors.

30 Dec 2019

Proton therapy has similar cure rates, fewer serious side effects compared with traditional radiation

Cancer patients who receive high-tech proton therapy experience similar cure rates and fewer serious side effects compared with those who undergo traditional X-ray radiation therapy, according to a study led by Washington University School of Medicine in St. Louis and the Perelman School of Medicine at the University of Pennsylvania.

28 Dec 2019

High BMI may improve the chance of survival in certain cancers

Above average or high BMI - often linked to cancers, diabetes, cardiovascular and other diseases - may in some cases improve the chance of survival among certain cancers, new research from Flinders University indicates.

26 Dec 2019

Synthetic mRNA nanoparticles restore tumor suppressor gene, make cancer cells susceptible to drugs

In preclinical experiments, investigators restored p53 using synthetic mRNA nanoparticles, making lung and liver cancer cells susceptible to available cancer drugs.

23 Dec 2019

Cancer Therapy News and Research

Nano-sized copper compounds together with immunotherapy can kill cancer cells

New method uses MRI, machine learning to forecast genetic mutations in glioma tumors

Administering enzalutamide results in significant increase in PSMA density on tumor surface

United States sees unprecedented fall in deaths from cancer

Study demonstrates feasibility of giving entire course of radiation in less than a second

PCORI announces new research funding opportunities to improve patient-centered outcomes

Researchers identify new mechanism associated with p53 mutation

Step counters could play role in predicting lung cancer treatment outcomes

Report highlights steady 26-year decline in overall cancer mortality

Researchers capture light emission from the eye of a patient undergoing radiotherapy

Low intensity pulsed ultrasound selectively targets cancer cells while sparing healthy cells

New drug compounds thwart master regulator of tumor growth, metastasis

Novel artificial intelligence algorithm helps detect brain tumor

Aspirin’s benefits may extend beyond heart health to colorectal cancer treatment

Researchers study new immunogenic properties of already existing anti-cancer drugs

New radiotracer can provide insights into how the heart recovers after myocardial infarction

New combination of antibodies leads to more effective tumor destruction

Proton therapy has similar cure rates, fewer serious side effects compared with traditional radiation

High BMI may improve the chance of survival in certain cancers

Synthetic mRNA nanoparticles restore tumor suppressor gene, make cancer cells susceptible to drugs

Event guide: 7th Allogeneic Cell Therapies Summit eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News